Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.28B
-
Number of holders
-
2029
-
Total 13F shares, excl. options
-
1.09B
-
Shares change
-
-4.76M
-
Total reported value, excl. options
-
$95.7B
-
Value change
-
-$386M
-
Put/Call ratio
-
0.94
-
Number of buys
-
1026
-
Number of sells
-
-850
-
Price
-
$88.10
Significant Holders of Medtronic plc - Common Stock (MDT) as of Q2 2023
2,180 filings reported holding MDT - Medtronic plc - Common Stock as of Q2 2023.
Medtronic plc - Common Stock (MDT) has 2,029 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.09B shares
of 1.28B outstanding shares and own 84.72% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (126M shares), BlackRock Inc. (115M shares), STATE STREET CORP (60.1M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (36M shares), Capital Research Global Investors (31.5M shares), GEODE CAPITAL MANAGEMENT, LLC (25.6M shares), BANK OF AMERICA CORP /DE/ (25.4M shares), WELLINGTON MANAGEMENT GROUP LLP (24.5M shares), MORGAN STANLEY (21.8M shares), and Bank of New York Mellon Corp (19.9M shares).
This table shows the top 2029 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.